INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Reducing Time To First-In-Human Trials With Robotic SFF Services
Discover how robotic gloveless isolator sterile fill-finish (SFF) systems can accelerate early-phase drug development, ensuring enhanced sterility and streamlined processes for biopharma innovation.
-
An Innovative Approach To Functional Outsourcing
The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.
-
Australia's Edge In Oncology And Nuclear Medicine Trials
Discover how we leverage Australia’s world-class clinical infrastructure, streamlined regulatory environment, and early-phase expertise to accelerate oncology and nuclear medicine trials.
-
Why Flexible Payment Options Matter For Clinical Trial Participants
In clinical trials, offering a variety of payment options is critical for participant retention and overall study success. How can you make the payment process simple and flexible?
-
Why Biotech CRO Partnerships Are Essential For Clinical Trial Success5/29/2025
For early-stage biotech companies, the road from discovery to market is fraught with challenges, and in this environment, strategic partnerships with CROs have become a cornerstone of clinical success.
-
Biopharma Giant Streamlines Infrastructure With Proprietary Software11/17/2025
Archiving legacy QMS systems into a centralized platform reduced costs, simplified access, and improved efficiency for a global diagnostics company undergoing quality process harmonization.
-
Why The Regional Site Manager Is The Swiss Army Knife Of Clinical Trial Monitoring1/28/2025
The Regional Site Manager (RSM) monitoring model eliminates numerous clinical trial risks by leveraging efficient, start-to-finish site management by a single, expert point of contact.
-
Setting A New Client Standard In Study Closeout Timelines4/4/2025
Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
-
GLP Compliance In A Modern Lab: What Compliant Actually Requires In 20253/9/2026
GLP compliance isn’t binary. Real defensibility depends on rigorous QA, validated electronic systems, and operational maturity — not just a label.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
The quality assurance (QA) team ensures the highest standards from pre-clinical to market by focusing on operational quality control, quickly identifying potential issues, and implementing necessary changes.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
We are manufacturing, packaging, and supply chain experts, harnessing experience and expertise to deliver you a seamless solution with the ultimate aim of improving the lives of patients.
-
Learn about the benefits of a Late Stage Customization approach, including how it can support a leaner, more responsive supply chain, ensuring life-changing therapies reach patients more efficiently.
-
In today’s ever-evolving clinical trial space, managing the expenses associated with conducting a study is more important – and fraught – than ever before.